Physician

Dennis Anthony Porto, MD

According to 2025 Medicare claims, Dennis Porto, MD (NPI: 1689012510) practices micrographic dermatologic surgery in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is SCHWEIGER DERMATOLOGY PLLC (NPI: 1831438662; TIN: 272373546) and primary practice location at 11235-3313. Porto is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Porto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 435 traditional Medicare patients, billed 2,475 HCPCS/CPT codes, and received $225,992 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 712 prescription claims across 318 beneficiaries totaling $162,244 in drug costs, led by Ketoconazole (Ketoconazole). Open Payments data shows 5 records totaling $83. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $85,166 to $225,992. Similarly, Part D prescription costs have risen steadily, from $56,480 to $162,244. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$120K$239K2019 Medicare payment: $85,166 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $110,303 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $130,068 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $103,724 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $239,282 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $225,992 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20193201,177$85,166
20203662,017$110,303
20213311,823$130,068
20223531,616$103,724
20233901,861$239,282
20244352,475$225,992

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$104K$208K2015 Drug cost: $56,480 (USD; Tot_Drug_Cst)2016 Drug cost: $110,343 (USD; Tot_Drug_Cst)2017 Drug cost: $20,832 (USD; Tot_Drug_Cst)2018 Drug cost: $89,201 (USD; Tot_Drug_Cst)2019 Drug cost: $17,110 (USD; Tot_Drug_Cst)2020 Drug cost: $41,851 (USD; Tot_Drug_Cst)2021 Drug cost: $76,780 (USD; Tot_Drug_Cst)2022 Drug cost: $151,787 (USD; Tot_Drug_Cst)2023 Drug cost: $208,185 (USD; Tot_Drug_Cst)2024 Drug cost: $162,244 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015137328$56,480
2016119266$110,343
201784167$20,832
2018138252$89,201
2019211465$17,110
2020240591$41,851
2021233691$76,780
2022198482$151,787
2023272631$208,185
2024318712$162,244

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more103129$103
11102Biopsy of related skin growth, first growth133154$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more230337$76
17000Destruction of precancer skin growth, 1 growth196285$44
17003Destruction of precancer skin growth, 2-14 growths152861$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KetoconazoleKetoconazole1153,332$1,973
Triamcinolone AcetonideTriamcinolone Acetonide1454,303$1,330
MetronidazoleMetronidazole19819$1,140
NystatinNystatin341,360$985
NyamycNystatin21615$751

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$83SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Dennis Anthony Porto, MD?

Tedicare shows public-source Medicare data for Dennis Anthony Porto, MD (NPI 1689012510), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dennis Anthony Porto, MD have ACO affiliation data?

Dennis Anthony Porto, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Dennis Anthony Porto, MD?

Dennis Anthony Porto, MD is linked to SCHWEIGER DERMATOLOGY PLLC (billing NPI 1831438662) in the available physician profile data.

Does Dennis Anthony Porto, MD have Open Payments data?

Dennis Anthony Porto, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.